SECAUCUS, N.J., July 31, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the leader in diagnostic information services, today announced the availability of the AD-Detect™ Test for Alzheimer's ...
Testing giant Quest Diagnostics is diving into the market for blood tests that aid in the early detection of Alzheimer’s disease. The disease afflicts millions of people around the world. But early ...
People can buy a blood test to check their levels of beta amyloid — a protein that’s known to contribute to Alzheimer’s disease. They can go directly to a Quest lab for bloodwork; the company’s ...
Add Yahoo as a preferred source to see more of our stories on Google. For the first time, people worried about their risk of Alzheimer’s disease can go online, order a blood test, and receive results ...
Quest Diagnostics unveiled a first-to-market blood test available for consumer purchase that helps assess the potential risk of developing Alzheimer’s disease. In adding AD-Detect, a single-blood-draw ...
In just one week, Secaucus-based Quest Diagnostics announced two new product offerings: one for at-home consumer use and another for physicians. The consumer product, Genetic Insights, helps people ...
In an oral presentation at the 2025 AAN Annual Meeting, Quest scientists presented data suggesting the test can accurately assess Alzheimer's disease pathology with greater than 90% sensitivity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results